Irving-based Caris Life Sciences filed to go public on the Nasdaq and revealed a significant revenue jump between 2023 and 2024. Still, the company remains unprofitable and is grappling with a large amoutn of debt. Learn all about what could be North Texas' next public company in this story, and check out a list of the region's biggest Wall Street movers and shakers.